RxDoctor Payments Data

Vinita Sudhakar

Hialeah, FLNPI 1548841174

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,542 of the $1,828 with a category attached, or 84.3%. It is spread thinly across 24 manufacturers, the largest accounting for just 11.1% — the pattern of someone who eats at a lot of different presentations.

$1,828in general payments, 2019–2025

Across 72 payments — averaging $25.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$204
  • AstraZeneca$190
  • Seagen Inc.$179
  • Merck$157
  • Sanofi$143
  • Daiichi Sankyo Inc.$128
  • plus $828 from 18 others

What the payments were for

  • Food & beverage$1,54284%
  • Education$28716%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Anastrozole23$285
Letrozole11$152
Prednisone16$46

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →